FDA Bupropion Study

Pharmacokinetic Study of Bupropion Hydrochloride Products with different Release Patterns

Purpose: To compare metabolism and absorption of Bupropion HCl products (generic Wellbutrin®) to Wellbutrin® in healthy participants. In this study participants will receive six formulations of Bupropion HCl and will complete a series of blood draws after each dose. The study involves a screening visit, six phases of medication and blood draws which span approximately 3 months.

This study has received approval from:  IRBMED  HUM00081894